VEGFA and adenomyosis: Recent findings further support this interplay; pharmacologic inhibition of VEGF signaling substantially reduces lesion severity and angiogenic factor expression in an adenomyosis mouse model, highlighting the importance of hormone-responsive angiogenic pathways in disease progression [26].